These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36503390)

  • 1. Superoxide Dismutase Inhibitors against Malaria, Leishmaniasis, and Chagas Disease: Systematic Review.
    Carneiro Araújo JS; de Mattos Oliveira L; de Andrade KVF; Guimarães Benevides R; Andrade Leite FH; Dos Santos Junior MC
    Curr Drug Targets; 2023; 24(2):201-210. PubMed ID: 36503390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flavonoids as efficient scaffolds: Recent trends for malaria, leishmaniasis, Chagas disease, and dengue.
    Boniface PK; Ferreira EI
    Phytother Res; 2019 Oct; 33(10):2473-2517. PubMed ID: 31441148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring N-myristoyltransferase as a promising drug target against parasitic neglected tropical diseases.
    Nascimento IJDS; Cavalcanti MAT; de Moura RO
    Eur J Med Chem; 2023 Oct; 258():115550. PubMed ID: 37336067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repositioning of leishmanicidal [1,2,3]Triazolo[1,5-a]pyridinium salts for Chagas disease treatment: Trypanosoma cruzi cell death involving mitochondrial membrane depolarisation and Fe-SOD inhibition.
    Martín-Escolano R; Martín-Escolano J; Ballesteros-Garrido R; Cirauqui N; Abarca B; Rosales MJ; Sánchez-Moreno M; Ballesteros R; Marín C
    Parasitol Res; 2020 Sep; 119(9):2943-2954. PubMed ID: 32607710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug design for neglected disease in Brazil.
    Giarolla J; Ferreira EI
    Mini Rev Med Chem; 2015; 15(3):220-42. PubMed ID: 25769971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antioxidant defence system as a rational target for Chagas disease and Leishmaniasis chemotherapy.
    Santi AMM; Murta SMF
    Mem Inst Oswaldo Cruz; 2022; 117():e210401. PubMed ID: 35239945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thiazole, thio and semicarbazone derivatives against tropical infective diseases: Chagas disease, human African trypanosomiasis (HAT), leishmaniasis, and malaria.
    Scarim CB; Jornada DH; Machado MGM; Ferreira CMR; Dos Santos JL; Chung MC
    Eur J Med Chem; 2019 Jan; 162():378-395. PubMed ID: 30453246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outlining the Molecules Tested
    de Melo Silva VG; da Conceição JM; Vieira Costa Silva CC; Leal AC; Araújo DL; Nunes JS; da Silva ETN; da Silva AJFS; de Barros Dias MCH; Lima Leite AC
    Curr Med Chem; 2023; 30(26):2932-2976. PubMed ID: 36200257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterocyclic N-oxides - A Promising Class of Agents against Tuberculosis, Malaria and Neglected Tropical Diseases.
    Dos Santos Fernandes GF; Pavan AR; Dos Santos JL
    Curr Pharm Des; 2018; 24(12):1325-1340. PubMed ID: 29663875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Potential Use of Peptides in the Fight against Chagas Disease and Leishmaniasis.
    Berhe H; Kumar Cinthakunta Sridhar M; Zerihun M; Qvit N
    Pharmaceutics; 2024 Feb; 16(2):. PubMed ID: 38399281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual Inhibition of Parasitic Targets: A Valuable Strategy to Treat Malaria and Neglected Tropical Diseases.
    Previti S; Di Chio C; Ettari R; Zappalà M
    Curr Med Chem; 2022; 29(17):2952-2978. PubMed ID: 34375176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential Triazole-based Molecules for the Treatment of Neglected Diseases.
    Mantoani SP; de Andrade P; Chierrito TPC; Figueredo AS; Carvalho I
    Curr Med Chem; 2019; 26(23):4403-4434. PubMed ID: 28748757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Nitro (NO
    Kamdem BP; Elizabeth FI
    Curr Drug Targets; 2021; 22(4):379-398. PubMed ID: 33371845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trypanothione Reductase and Superoxide Dismutase as Current Drug Targets for Trypanosoma cruzi: An Overview of Compounds with Activity against Chagas Disease.
    Beltran-Hortelano I; Perez-Silanes S; Galiano S
    Curr Med Chem; 2017 May; 24(11):1066-1138. PubMed ID: 28025938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galectins in Protozoan Parasitic Diseases: Potential Applications in Diagnostics and Therapeutics.
    Meira C; Silva J; Quadros H; Silva L; Barreto B; Rocha V; Bomfim L; Santos E; Soares M
    Cells; 2023 Nov; 12(23):. PubMed ID: 38067100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unlocking the potential of snake venom-based molecules against the malaria, Chagas disease, and leishmaniasis triad.
    Almeida JR; Gomes A; Mendes B; Aguiar L; Ferreira M; Brioschi MBC; Duarte D; Nogueira F; Cortes S; Salazar-Valenzuela D; Miguel DC; Teixeira C; Gameiro P; Gomes P
    Int J Biol Macromol; 2023 Jul; 242(Pt 2):124745. PubMed ID: 37150376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selenium Derivatives as Promising Therapy for Chagas Disease:
    Martín-Escolano R; Etxebeste-Mitxeltorena M; Martín-Escolano J; Plano D; Rosales MJ; Espuelas S; Moreno E; Sánchez-Moreno M; Sanmartín C; Marín C
    ACS Infect Dis; 2021 Jun; 7(6):1727-1738. PubMed ID: 33871252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiprotozoal compounds: state of the art and new developments.
    Astelbauer F; Walochnik J
    Int J Antimicrob Agents; 2011 Aug; 38(2):118-24. PubMed ID: 21549569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leishmaniasis and Chagas disease: Is there hope in nanotechnology to fight neglected tropical diseases?
    Scariot DB; Staneviciute A; Zhu J; Li X; Scott EA; Engman DM
    Front Cell Infect Microbiol; 2022; 12():1000972. PubMed ID: 36189341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.